Surgical skill in a nutshell
Vol. 16 No. 1 (2024)
A lower eyelid and cheek defect reconstruction
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 16 October 2023
506
Views
369
Downloads
15
HTML
Authors
A 91-year-old woman presented with a recurrent cutaneous squamous cell carcinoma involving the right lower eyelid and cheek. Recurrence occurred after one month from an incomplete surgical excision: histology reported a tumor infiltration of the subcutaneous tissue and deep margin. [...]
Downloads
Download data is not yet available.
Citations
Kooistra LJ, Scott JF, Bordeaux JS. Cicatricial ectropion repair for dermatologic surgeons. Dermatol Surg 2020;46:341-7.
Elliot D, Britto JA. Tripier’s innervated myocutaneous flap 1889. Br J Plast Surg 2004;57:543-9.
Patel SB, Buttars BR, Roy DB. Mustardé flap for primary nasal sidewall defect post-Mohs micrographic surgery. JAAD Case Rep 2022;23:151-4.
NCCN Guidelines: Squamous Cell Skin Cancer, Version 1. J Natl Compr Canc Netw JNCCN 2023. Available from: https://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf.
How to Cite
1.
Cioppa V, Rubegni P, De Piano E. A lower eyelid and cheek defect reconstruction. Dermatol Reports [Internet]. 2023 Oct. 16 [cited 2026 Apr. 18];16(1). Available from: https://journals.pagepress.net/dr/article/view/9859
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
